▸ Hospitals · Pharma · Biotech · Medical Research

For patient-tier security.

Hospital networks. Pharmaceutical majors. Biotech and gene-therapy research. Medical device manufacturers. The sector where ransomware no longer attacks data — it attacks patients. Where IP theft is state-sponsored. Where supply-chain compromise reaches into surgical theatres.

Healthcare faces a structurally different threat surface from most enterprise sectors. Patient lives are directly exposed. Research IP is targeted by state actors with multi-decade horizons. Supply chains cross dozens of jurisdictions. Regulatory complexity creates security gaps rather than closing them. Fiive Eyes operates as the layer that engages where conventional healthcare security stops — pre-emptively against named threat actors, with response capability calibrated to clinical reality.

▸ Why Fiive Eyes

Built for your specific threat geometry.

Each sector faces a different operating reality. Fiive Eyes is calibrated — not customized — to the structural specifics of how you operate, what's at stake, and what success looks like.

01

Life-safety calibrated

Engagements designed around clinical operational continuity. We don't disrupt to defend — we preempt so disruption never happens.

02

IP and research protection

IFC0 monitoring tuned to nation-state IP-theft operations targeting biotech, gene therapy, vaccine research, and medical device innovation.

03

Ransomware pre-emption

HUNT engagement against ransomware operations before they reach clinical infrastructure. Detection at staging, neutralization at infrastructure, not at impact.

04

Principal and patient protection

C-suite and high-value patient protection for sovereign-tier clientele, ruling-family medical needs, geopolitically exposed individuals.

▸ Capability mapping

Which zones apply.

Not every engagement requires every zone. The architecture exists so capability matches need — precisely, proportionately, sovereignly.

HUNT Pre-emptive engagement against ransomware operations and state-aligned IP-theft actors. IFC0 Biotech-specific threat intelligence, dark-web monitoring for clinical credentials, supply-chain compromise detection. Q-311 Post-quantum migration for clinical systems, research IP, and principal-tier patient communications.
▸ Engagement model

How an engagement begins.

Four phases. Discreet at every stage. Bespoke to your operational reality.

01

Clinical-grade brief

Threat assessment calibrated to your clinical, research, or commercial profile. Tone matches sector.

02

Scope definition

Engagement focused on specific threat geometries — ransomware, IP theft, supply-chain risk, principal protection.

03

Integration phase

Deployment alongside existing healthcare security operations with minimal clinical disruption.

04

Continuous engagement

24/7 monitoring with escalation protocols calibrated to clinical reality; quarterly executive review.

Sovereign capability. Sector-specific engagement.

Request Healthcare Brief